Sleep among bereaved caregivers of patients admitted to hospice: a 1-year longitudinal pilot study. by Lerdal, Anners et al.
UCSF
UC San Francisco Previously Published Works
Title
Sleep among bereaved caregivers of patients admitted to hospice: a 1-year longitudinal 
pilot study.
Permalink
https://escholarship.org/uc/item/0mk885m8
Journal
BMJ open, 6(1)
ISSN
2044-6055
Authors
Lerdal, Anners
Slåtten, Kari
Saghaug, Elisabeth
et al.
Publication Date
2016-01-04
DOI
10.1136/bmjopen-2015-009345
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Sleep among bereaved caregivers of
patients admitted to hospice: a 1-year
longitudinal pilot study
Anners Lerdal,1,2 Kari Slåtten,3 Elisabeth Saghaug,2 Ellen Karine Grov,4,5
Are Peder Normann,2 Kathryn A Lee,6 Bjørn Bjorvatn,7,8 Caryl L Gay2,6
To cite: Lerdal A, Slåtten K,
Saghaug E, et al. Sleep
among bereaved caregivers of
patients admitted to hospice:
a 1-year longitudinal pilot
study. BMJ Open 2016;6:
e009345. doi:10.1136/
bmjopen-2015-009345
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-009345).
Received 8 July 2015
Accepted 2 November 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Anners Lerdal; anners.
lerdal@medisin.uio.no
ABSTRACT
Objectives: This pilot study aimed to describe the
sleep of partners and other family caregivers prior to
and in the first year after a hospice patient’s death. The
study also evaluated the feasibility of the study
protocol and determined the effect sizes in preparation
for a full-scale study.
Design: The pilot study used a longitudinal,
descriptive and comparative design.
Setting and participants: Participants included
primary family caregivers of patients admitted to a
hospice in Oslo, Norway.
Primary outcome: Caregiver sleep was measured
subjectively with the Pittsburgh Sleep Quality Index
(PSQI) and objectively using wrist actigraphy for 4
nights and 3 days at three different times: during the
hospice stay, and at 6 and 12 months after the
patient’s death.
Results: 16 family caregivers (10 partners and 6 other
family members) completed the 1-year study protocol.
Overall, sleep quality and quantity were stable over
time and at each assessment, approximately half of the
sample had poor sleep quality, both by self-report and
objective measures. However, the sleep trajectories
differed significantly over time, with older caregivers
(≥65 years) having significantly longer sleep durations
than younger caregivers (<65 years). Furthermore,
sleep quality also differed over time depending on the
caregiver’s relationship to the patient, with partner
caregivers having significantly worse sleep quality than
other family caregivers.
Conclusions: Caring for a dying family member is
known to interfere with sleep, yet little is known about
bereaved caregivers. The results of this pilot study
demonstrate the feasibility of the longitudinal study
protocol and indicate that sleep problems are common
for caregivers and continue into the bereavement
period, particularly for partner caregivers. The
caregiver’s relationship to the patient may be an
important factor to consider in future studies.
INTRODUCTION
Sleep disturbance is a common and often
distressing symptom for caregivers, particu-
larly caregivers who provide end-of-life
care.1–5 Inadequate sleep may lead to poorer
long-term outcomes and stress-related disor-
ders.6 Prior studies have reported that some
groups of caregivers may be vulnerable to
developing sleep disturbances due to older
age, male gender, role overload and depres-
sive symptoms.7 During the bereavement
period, women have been reported to
experience more severe anxiety than
bereaved men, although gender was not asso-
ciated with prolonged grief or depression.8
The caregiver’s relationship to the patient
(ie, partner or other family member) has not
been associated with sleep disturbance
during the caregiving period in several prior
studies,1 2 9 but to the best of our knowledge,
it has not been examined during the
bereavement period.
Few longitudinal studies have evaluated
sleep across the transition from end-of-life
caregiving into the bereavement period.7 10
Nonetheless, this transition may be a critical
health risk factor for caregivers adjusting to
Strengths and limitations of this study
▪ A strength of the study is the use of both object-
ive and subjective measures of sleep.
▪ The inclusion of sleep measures before and after
the patient’s death is also a strength.
▪ While the findings indicate a high prevalence of
sleep disturbance among caregivers, particularly
partners, during the first year of bereavement the
small sample size does not allow generalisation
of the study findings.
▪ The 50% enrolment rate and the 20% attrition
rate may limit the representativeness of the
sample, and suggest that strategies for improv-
ing participant enrolment and retention may
need further consideration in a full-scale study of
bereaved caregivers.
▪ The patients and caregivers were recruited while
receiving care at a hospice, and the findings may
differ for caregivers of patients receiving home
care service.
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the loss of their loved one. Furthermore, sleep during
this period may play an important role in health, as
sleep disturbance can exacerbate existing distress,
whereas adequate sleep can foster optimal physical,
mental and social health.
The purpose of this pilot study was to examine the
feasibility of conducting a longitudinal sleep study of
bereaved family caregivers for patients in hospice and
describe the sleep trajectories of family caregivers from
the hospice period until 1 year after the patient’s death.
We hypothesised that family caregivers would have high
rates of clinically significant sleep disturbance (based on
objective and subjective measures), not only during the
caregiving period but into the bereavement period as
well, and that partners would have worse sleep trajector-
ies than other family caregivers.
METHODS
This study reports the findings from a longitudinal pilot
study of caregivers for patients admitted to Lovisenberg
Hospice in Oslo, Norway. Data were collected from
January 2012 to February 2014 from hospice patients
and their primary caregivers; only data from caregivers
are included in this report. Caregivers were also assessed
6 and 12 months after the patient’s death. Informed
written consent was obtained from all patients and their
caregivers.
Participants
Consecutive patients were recruited if they met the fol-
lowing inclusion criteria: (1) admitted for 24-h hospice
care within the past week, (2) evaluated by their health
professional to be in the terminal stage of their disease,
(3) ≥18 years of age, (4) could specify a primary care-
giver and (5) had the cognitive and verbal capacity to
comprehend Norwegian verbal cues. All hospice patients
had advanced cancer. Each patient who consented to
participate specified their primary caregiver who was
also recruited for participation. Caregivers who were
≥18 years of age and consented to participate were
included (figure 1). Sixteen family caregivers (10 part-
ners and 6 other family members) completed the 1-year
study protocol.
Measurements
Perceived sleep quality
Caregivers’ sleep quality during the prior month was
assessed with the 19-item Pittsburgh Sleep Quality Index
(PSQI).11 Total scores range from 0 to 21, where higher
scores represent poorer sleep quality, and scores >5 are
considered clinically significant.11 The PSQI has seven
components: sleep quality, sleep latency, sleep duration,
habitual sleep efficiency, sleep disturbance, sleep medi-
cation use and daytime dysfunction. Component scores
range from 0 to 3, with higher scores reflecting worse
sleep. Internal consistency and test-retest reliability for
the original12 and Norwegian versions are satisfactory.13
Sleep–wake pattern
Sleep quantity and sleep disruption were estimated with
the Motionlogger Actigraph (AA-32 Ambulatory
Monitoring Inc, Ardsley, New York, USA), a valid and
reliable instrument for assessing sleep–wake behaviour
over several nights and days.14 It is worn like a wristwatch
and records movement in 1 min intervals to estimate
sleep and wake time. Its correspondence with polysom-
nography is 91–93% in healthy people.14 In this study,
the actigraph was worn for 4 nights and 3 days.
Actigraphs recorded in zero-crossing mode, and activity
counts were analysed with the Cole-Kripke algorithm
from ActionW software program, V.2.4 (Ambulatory
Monitoring Inc). Sleep diaries facilitated actigraphy
scoring for bedtime and final wake time. Night-time
sleep parameters were based on standard intervals from
21:00 to 08:59, and included measures of both sleep
quantity (total night-time sleep duration) and sleep dis-
ruption (mean number of awakenings and mean wake
after sleep onset (WASO)). WASO was reported as the
number of minutes spent awake after initially falling
asleep, as well as a percentage standardised by time in
bed. WASO>30 min is considered clinically significant
and suggestive of maintenance insomnia. Daytime sleep
Figure 1 Flowchart showing the recruitment of
patient-caregiver dyads.
2 Lerdal A, et al. BMJ Open 2016;6:e009345. doi:10.1136/bmjopen-2015-009345
Open Access
quantity was estimated as the number of min spent
asleep between 09:00 and 20:59. Total sleep quantity
during each 24 h period was calculated as the sum of
night and day sleep, and mean values were calculated
across the first three 24 h periods. As bedtimes and wake
times were only roughly estimated in the sleep diaries,
sleep onset latency and sleep efficiency were not
included in this study.
Data analysis
An initial sample size of 20 caregivers was considered suf-
ficient for determining the protocol’s feasibility (includ-
ing enrolment and retention rates) and estimating effect
sizes for change over time, and for differences between
partners and other family caregivers. Data were analysed
using SPSS V.22.0. Descriptive statistics summarised
demographic characteristics and sleep outcome variables.
Group differences were assessed using Fisher’s exact test
and analysis of variance. In separate analyses evaluating
age group (age <65 or ≥65 years) and caregiver group
(partner or other), repeated measures analysis of vari-
ance was used to evaluate the effects of group, time (in
hospice, and at 6 and 12 months follow-up), and the
interaction of group by time. Relevant covariates were
also included in the models. Significance of p<0.05 was
used for all analyses. Effect sizes of η2 values >0.04 and ϕ
values >0.2 were considered clinically relevant.15
RESULTS
Descriptive statistics
As shown in figure 1, the enrolment rate was 50% and
the attrition rate was 20%. Sixteen caregivers completed
all three assessments and were included in the analysis
(figure 1). Sociodemographic characteristics are shown
in table 1. Partners (n=10) were older on average com-
pared to other family caregivers (n=6). Most patients
were female (n=10), and the six male patients were all
cared for by their female partners, resulting in a signifi-
cant association between patient gender and the care-
giver’s relationship to the patient (partner vs other
family member). Although not statistically significant in
this small sample, there were clinically relevant group
differences in caregiver gender and work status.
Sleep measures over time
Mean PSQI scores for each assessment are reported in
table 2. Scores generally indicated significant sleep
Table 1 Sociodemographic characteristics for the pilot sample of caregiver’s relationship to the patient (N=16)
Sociodemographic characteristics
Total
N=16
Partners
n=10
Other family
n=6 p Value Effect size
Caregiver characteristics
Age (years), mean (SD) 58.6 (13.8) 65.1 (9.9) 47.7 (11.3) 0.009* η2=0.399
Range 36–77 46–77 36–72
Gender, n (%) 0.14† ϕ=0.372
Male 3 (19) 3 (30) 0 (0)
Female 13 (81) 7 (70) 6 (100)
Education, years >0.99† ϕ=0.067
≤13 6 (38%) 4 (40%) 2 (33%)
14 or more 10 (62%) 6 (60%) 4 (67%)
Work status 0.12† ϕ=0.516
In paid job 8 (50%) 3 (30%) 5 (83%)
Not in paid job 8 (50%) 7 (70%) 1 (17%)
Relationship status 0.38† ϕ=0.333
In paired relationship 15 (94%) 10 (100%) 5 (83%)
Not in relationship 1 (6%) – 1 (17%)
Relationship to patient‡
Partner/spouse 10 (60%) 10 (100%)
Child 4 (25%) 4 (66%)
Parent 1 (10%) 1 (17%)
Sibling 1 (5%) 1 (17%)
Patient characteristics
Age (years), mean (SD) 69.1 (9.1) 69.5 (10.6) 68.3 (6.7) 0.81§ η2=0.004
Range 36–84 46–84 36–72
Gender, n (%) 0.034† ϕ=0.600
Male 6 (38) 6 (60) –
Female 10 (62) 4 (40) 6 (100)
Statistically significant differences are indicated in bold type.
*F(1,14)=9.29.
†Fisher’s Exact.
‡No analyses since groups differ by definition.
§F(1,14)=0.06.
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disturbance, and at each of the three assessments—in
hospice, at 6 and 12 months follow-up—approximately
half of the caregivers scored above the PSQI clinical
cut-off of 5 (62.5%, 43.8% and 50%, respectively).
Repeated measures analysis indicated that PSQI scores
were stable across the three assessments, with no signifi-
cant effect of time. The PSQI component scores indi-
cated that difficulty falling asleep, waking up during the
night, and daytime dysfunction were the most commonly
reported sleep problems. The component scores were
also stable over time, with only the sleep medication
component scores improving (ie, scores decreased) sig-
nificantly over time.
Objective measures of sleep indicated significant sleep
disruption at each of the three assessments, and all but
two of the caregivers had WASO>30 min. With respect to
sleep quantity, the mean night-time sleep duration was
7.5–8 h, well within the recommended range. Caregivers
also had an average of 30 min of daytime napping, such
that their average sleep time over 24 h exceeded 8 h at
each assessment.
Sleep trajectories by caregiver characteristics
To determine the effect of the caregiver’s age on their
sleep trajectories from the hospice period until 1 year
after the patient’s death, a repeated measures analysis of
variance was conducted, with caregiver age included as a
covariate. In these analyses, age was a significant factor
for both night-time sleep (F[1,14]=11.2, p=0.005,
η2=0.44) and total sleep in 24 h (F[1,14]=7.05, p=0.019,
η2=0.34). To illustrate the influence of caregiver age, the
sample was split into those <65 and ≥65 years, and the
sleep trajectories for night-time sleep duration in the
two age groups are shown in figure 2. Given the small
number of men in this sample (n=3), the effect of
caregiver sex could not be reliably evaluated.
Figure 2 Night-time sleep
duration over time by caregiver
age group. Older caregivers
obtained consistently more sleep
at night compared to younger
caregivers (effect of age group: F
[1,14]=6.55, p=0.023, η2=0.32).
Table 2 Sleep measures over time, mean (SD), N=16
Sleep measure
In
hospice 6 Months 12 Months
Self-reported sleep quality
PSQI total score 6.56 (3.10) 5.81 (3.35) 5.94 (2.57)
PSQI sleep quality 0.44 (1.03) 0.38 (0.89) 0.25 (0.77)
PSQI sleep onset
latency
1.13 (0.74) 1.00 (0.89) 0.94 (1.12)
PSQI sleep
duration
0.50 (0.82) 0.63 (0.89) 0.81 (0.83)
PSQI habitual
sleep efficiency
0.88 (0.96) 1.13 (1.20) 0.94 (1.18)
PSQI sleep
disturbance
1.44 (0.51) 1.31 (0.60) 1.25 (0.45)
PSQI sleep
medication*
0.56 (0.81) 0.13 (0.34) 0.25 (0.45)
PSQI daytime
dysfunction
1.69 (0.95) 1.25 (0.86) 1.50 (0.82)
Actigraph measures
Sleep disruption
Night
awakenings, n
7.13 (4.39) 8.96 (5.14) 8.68 (5.02)
WASO, min 105 (80) 87 (48) 89 (54)
WASO, % 16.7 (10.8) 14.9 (7.0) 15.4 (9.5)
Sleep quantity
Total sleep in
24 h, h
8.30 (1.29) 8.16 (1.18) 8.60 (1.64)
Total night
sleep, h
7.73 (1.10) 7.64 (0.80) 7.78 (1.13)
Total day sleep,
min
33.2 (28.9) 30.9 (28.1) 48.8 (43.4)
PSQI total scores >5 are clinically significant and component
scores range is 0–3, with higher scores indicating poorer sleep.
The PSQI assessed sleep during past month, while actigraphy
measures assessed average sleep over 4 nights and 3 days.
There were no significant changes over time for any sleep
measure, except the PSQI sleep medication component.
*F=4.27, p=0.042 (Greenhouse-Geisser correction), η2=0.22.
PSQI, Pittsburgh Sleep Quality Index; WASO, wake after sleep
onset, a measure of sleep disruption.
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Comparisons of partners and other family caregivers
To evaluate whether partners and other family caregivers
had similar sleep trajectories during the hospice period
until 1 year after the patient’s death, repeated measures
analysis of variance was conducted for each sleep
measure, with the caregiver’s relationship to the patient
included as the between-subjects factor. Given the differ-
ence in age between partners and other family care-
givers, and the potential influence of age on sleep, the
caregiver’s age was also included as a covariate. Results
indicated that partner caregivers reported consistently
worse sleep quality than other family caregivers;
although the self-reported sleep quality of other family
caregivers improved over time, the interaction between
time and caregiver type was not statistically significant
(p=0.195, η2=0.12; table 3 and figure 3). This pattern
was also evident in the objective actigraphy measures of
sleep disruption (WASO in minutes and as a per cent of
time in bed), with partner caregivers having increasing
levels of sleep disruption over time, while the sleep dis-
ruption of other family caregivers improved over time
(figure 4). Although the effect did not reach statistical
significance in this small sample, a similar pattern was
observed for number of night awakenings and the effect
size estimate suggests the effect may be clinically signifi-
cant. There was no difference between partners and
other family caregivers for sleep quantity based on acti-
graphy values; both types of caregivers obtained similar
amounts of sleep over time.
DISCUSSION
Few longitudinal studies have evaluated sleep across the
transition from end-of-life caregiving into the bereave-
ment period. The results of this pilot study indicate that
poor sleep quality is common among family caregivers
Table 3 Sleep measures over time by caregiver’s relationship to patient and adjusted for caregiver age, mean (95% CI),
N=16
Sleep measure
Partners
n=10
Other family
n=6 Statistics (with p<0.10)
Self-reported sleep quality
PSQI total score p=0.040*, η2=0.29
In hospice 7.18 (4.70 to 9.65) 5.54 (2.14 to 8.94)
6-month follow-up 7.45 (5.08 to 9.81) 3.09 (−0.16 to 6.34)
12-month follow-up 7.69 (6.24 to 9.14) 3.02 (1.03 to 5.01)
Actigraph measures
Sleep disruption
WASO, min p=0.002†, η2=0.37
In hospice 70 (12 to 128) 165 (85 to 244)
6-month follow-up 116 (86 to 147) 38 (−4 to 80)
12-month follow-up 102 (60 to 144) 67 (9 to 124)
WASO, % p=0.007†, η2=0.32
In hospice 12.0 (4.1 to 20.0) 24.5 (13.6 to 35.4)
6-month follow-up 19.1 (14.5 to 23.6) 7.9 (1.7 to 14.1)
12-month follow-up 17.5 (10.0 to 25.0) 11.8 (1.5 to 22.1)
Night awakenings, n p=0.067†, η2=0.19
In hospice 7.1 (3.56 to 10.6) 7.2 (2.4 to 12.1)
6-month follow-up 10.8 (6.8 to 14.7) 6.0 (0.6 to 11.3)
12-month follow-up 10.3 (6.5 to 14.1) 6.0 (0.7 to 11.3)
Sleep quantity
Total sleep in 24 h, h –
In hospice 8.34 (7.44 to 9.25) 8.24 (7.00 to 9.48)
6-month follow-up 8.49 (7.64 to 9.34) 7.61 (6.44 to 8.78)
12-month follow-up 8.89 (7.75 to 10.0) 8.12 (6.55 to 9.69)
Total night sleep, h –
In hospice 7.80 (7.04 to 8.57) 7.61(6.56 to 8.66)
6-month follow-up 7.87 (7.30 to 8.44) 7.26 (6.48 to 8.05)
12-month follow-up 7.83 (7.05 to 8.61) 7.68 (6.61 to 8.75)
Total day sleep, min –
In hospice 31.3 (8.0 to 54.7) 36.4 (4.4 to 68.5)
6-month follow-up 37.2 (15.5 to 58.9) 20.4 (−9.5 to 50.2)
12-month follow-up 63.8 (31.9 to 95.8) 23.8 (−20.1 to 67.7)
The PSQI assessed sleep during past month, while actigraphy measures assessed average sleep over 4 nights and 3 days.
*Main effect for group (partner vs other family).
†Interaction effect for group by time.
PSQI, Pittsburgh Sleep Quality Index; WASO, wake after sleep onset, a measure of sleep disruption.
Lerdal A, et al. BMJ Open 2016;6:e009345. doi:10.1136/bmjopen-2015-009345 5
Open Access
of patients in hospice and that their poor sleep con-
tinues through the first year of bereavement. However,
sleep trajectories during this transition differ depending
on at least two caregiver characteristics. First, older care-
givers (≥65 years) had significantly longer sleep dura-
tions than younger caregivers (<65 years), although both
groups generally obtain the recommended minimum
sleep of 7 h per night. Second, partner caregivers
reported consistently worse sleep disruption than other
family caregivers, and objective actigraphy measures
indicated that their sleep disruption actually worsened
over time, while sleep improved for other family care-
givers after the caregiving ended.
Partners had less sleep disruption (WASO) than other
family caregivers after hospice admission (figure 4).
However, sleep was less disrupted over time for other
family caregivers and more disrupted for partner care-
givers. These findings differ from prior studies that did
not find differences by caregiver type.1 9 The non-
partner caregivers in our sample were younger and
more likely to be employed than the partner caregivers,
and thus may have had work and other family
responsibilities that interfered with sleep. It is also pos-
sible that the hospice admission allowed the partner to
increase their sleep time for recovery from the chronic
sleep debt experienced while the patient was at home.
Grov16 points out that bereavement support is part of
the palliative care philosophy. However, the bereavement
process likely differs for partners compared to other
family caregivers. While both adapt to a new life situ-
ation after the death of the patient, for partners this can
mean completely redefining the focus of their life.17
According to Exley and Allen18 and Soothill et al,19 it is
important to understand the impact of loss of a signifi-
cant other on social identity and to note that ‘home’ is
not merely a physical space, but the social and emo-
tional relationships contained therein are also crucial.
Understanding the partner’s future role when left
alone requires important consideration of key variables
such as understanding the role of family communication
as it relates to end-of-life care.20 According to Kissane
et al,21–23 there is a large body of evidence from psych-
iatry that focuses on communication patterns and con-
flicts within families, and how these patterns and
Figure 3 Self-reported sleep
quality over time by caregiver
type, adjusting for caregiver age.
Partner caregivers reported
consistently worse sleep quality
over time compared to other
family caregivers (effect of
caregiver type: F[1,13] =5.18,
p=0.040, η2=0.29). Covariate of
caregiver age evaluated at a
mean value of 58.6 years.
Figure 4 Objectively measured
sleep disruption over time by
caregiver type, adjusting for
caregiver age. Partners had less
sleep disruption than other family
caregivers while the patient was
in hospice, but the sleep
disruption improved over time for
other family caregivers and
worsened for partner caregivers
(interaction effect of time by
caregiver type: F[2,26]=7.76,
p=0.002, η2=0.37). Covariate of
caregiver age evaluated as a
mean value of 58.6 years.
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conflicts can affect family members during the caregiv-
ing period and in bereavement. Understanding the care-
giver’s sleep patterns, often characterised as ‘sleeping
with one eye open’ when the patient is alive, is import-
ant for the caregivers’ quality of life and perceived
burden. This perspective extends into the bereavement
period as well.1 3 7 8 24 25
Carter et al10 point out that a caregiver must often
structure his or her life around the patient’s needs.
However, once the patient dies, that structure is lost and
bereaved caregivers are vulnerable to insomnia, depres-
sion and complicated grief. Their results would suggest
that the structure provided in cognitive–behavioural
therapy may be an effective intervention for treating
both the insomnia and depression commonly experi-
enced by a bereaved family caregiver.
The results of this study should be considered in light
of several limitations. The 50% enrolment rate and the
20% attrition rate suggest that this sample may not be
representative of the larger population of caregivers of
hospice patients. Strategies for improving participant
enrolment and retention may need further consider-
ation in a full-scale study of bereaved caregivers.
Moreover, potential study participants experiencing sig-
nificant distress were often not approached, which likely
resulted in a sampling bias towards less distressed fam-
ilies. As such, these findings may underestimate sleep
disturbance in this population. The patients and care-
givers in this study were recruited while receiving care at
a hospice, and the findings may differ for caregivers of
patients receiving home care service. The study did not
include a comparison group. In addition, actigraphy esti-
mates are most reliable when sleep is monitored for
7 days or more, but to minimise participant burden, a
shorter monitoring day was used, which may limit the
reliability of the actigraphy estimates. Moreover, actigra-
phy estimates of sleep onset latency and sleep efficiency
were not reported, and future studies should obtain
more precise bed times and wake times so that these
additional sleep parameters can be accurately estimated.
Finally, the small sample size limits the generalisation of
the study findings and precluded analysis of the effects
of other caregiver characteristics (eg, gender, work
status, living arrangement, other life stressors, comorbid-
ities, medications and pre-existing symptoms/condi-
tions), which may have influenced the caregiver’s sleep.
Depression often co-occurs with sleep disturbance, but
the number of caregivers reporting depression in this
small sample was insufficient to explore the relationship
between sleep, depression and grief. Such factors need
to be examined in future studies. A future study to
explore these relationships in a larger sample is planned
and has received ethics approval.
CONCLUSION
Family caregivers of hospice patients experience poor
sleep quality, and this poor sleep generally extends at
least through the first year of bereavement. However, the
quality and quantity of sleep over time are influenced by
caregiver characteristics such as age and relationship to
the patient. Future studies are needed to identify other
characteristics of caregivers at risk for poor sleep. A
better understanding of these characteristics will help in
the development and testing of tailored intervention
strategies for this vulnerable population.
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